arrow
M

Masashi Matsuda

Harvard Medical School
H指数:13
被引数:859

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Preclinical efficacy of combination therapy with allogeneic induced pluripotent stem cell-derived invariant natural killer T and α-galactosylceramide-pulsed antigen-presenting cells

异基因诱导多能干细胞来源的不变自然杀伤T细胞与α-半乳糖神经酰胺脉冲抗原呈递细胞联合疗法的临床前疗效

2026-03-290
OA
A T-cell receptor targeting RUNX1 frameshift mutations in acute myeloid leukemia

靶向急性髓系白血病中RUNX1移码突变的T细胞受体

Leukemia
IF13.4
2025-12-120
OAAI
The role of IL-4+ memory T cells in SARS-CoV-2 booster vaccination

IL-4+记忆T细胞在SARS-CoV-2加强疫苗接种中的作用

2025-09-010
PRE
Monoclonal antibodies against human TMPRSS2 prevent infection by any SARS-CoV-2 variant

针对人TMPRSS2的单克隆抗体可阻止任何SARS-CoV-2变种的感染

2025-08-220
OAAI
SETBP1 is dispensable for normal and malignant hematopoiesis
LEUKEMIA
IF13.4
2023-07-183
OA
Deficiency of TMEM53 causes a previously unknown sclerosing bone disorder by dysregulation of BMP-SMAD signaling

TMEM53的缺乏通过bmp-smad信号的失调导致先前未知的硬化性骨疾病

2021-04-0612
OAAI
Human NK cell development in hIL-7 and hIL-15 knockin NOD/SCID/IL2rgKO mice
2019-04-0148
OAAI
Co-activation of macrophages and T cells contribute to chronic GVHD in human IL-6 transgenic humanised mouse model
2019-03-0125
OAAI
Murine induced pluripotent stem cells can be derived from and differentiate into natural killer T cells
2010-07-0159
OA